Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial  Robert J. Shulman, Emily B. Hollister,

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

2015 James W. Freston Single Topic Conference: A Renaissance in the Understanding and Management of Irritable Bowel Syndrome Lin Chang, Margaret M. Heitkemper,
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial  Robert J. Shulman, Emily B. Hollister,
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation  Satish S.C. Rao, Eamonn M.M. Quigley,
Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.
Effect of Linaclotide on Severe Abdominal Symptoms in Patients With Irritable Bowel Syndrome With Constipation  Satish S.C. Rao, Eamonn M.M. Quigley,
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Volume 139, Issue 6, Pages e2 (December 2010)
Millie D. Long, Bruce E. Sands 
Charles D. Gerson, Mary-Joan Gerson 
Efficacy of a Chinese Herbal Medicine in Providing Adequate Relief of Constipation- predominant Irritable Bowel Syndrome: A Randomized Controlled Trial 
Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation  Sarah Ballou, Alissa Beath, Ted J. Kaptchuk, William.
Pichamol Jirapinyo, Christopher C. Thompson 
Volume 133, Issue 5, Pages (November 2007)
Treatment of Esophageal (Noncardiac) Chest Pain: An Expert Review
A Very Low-Carbohydrate Diet Improves Symptoms and Quality of Life in Diarrhea- Predominant Irritable Bowel Syndrome  Gregory L. Austin, Christine B. Dalton,
James W.T. Toh, Hasitha Balasuriya, Peter Stewart 
A Shocking Cystory Clinical Gastroenterology and Hepatology
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial  Liang Zheng, Yaoliang Lai, Weimin Lu, Baiwen Li,
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome  Megan Rossi, Raphael Aggio,
Amy E. Schindler, Jonathan A. Schneider, Keith L. Obstein 
Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea  Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.
Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study  Henry P. Parkman,
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Miles Basil, Anita Pudusseri, Robert Lowe 
Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial  Karen A. Frankwich, Jeremy Egnatios,
Activity-Based Costing and Management in a Hospital-Based GI Unit
Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased  Fiona D.M. van Schaik, Martijn G.H.
Issue Highlights Clinical Gastroenterology and Hepatology
Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea  Reginald V. Fant,
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year  Jasmine K. Zia, Pamela Barney,
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic.
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva 
Effects of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation: A Meta-analysis  Elizabeth J. Videlock, Vivian.
New Models of Gastroenterology Practice
Unusual Cause of Abdominal Pain: Peutz–Jeghers Syndrome
Short-term and Long-term Efficacy of Psychological Therapies for Irritable Bowel Syndrome: A Systematic Review and Meta-analysis  Kelsey T. Laird, Emily.
Rebecca M. Lovell, Alexander C. Ford 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia  Alexander C. Ford, Avantika Marwaha,
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial  Manish Kumar Lunia, Barjesh Chander Sharma, Praveen.
Unusual Cause of Fever and Abdominal Pain: Acute Suppuration of the Pancreas Duct and Endoscopic Management  Robert Hirten, Divyesh V. Sejpal, Arvind.
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: Analysis of two controlled.
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Abdominal Aortitis Associated With Autoimmune Pancreatitis
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome  Luise M. Begtrup, Anne Line Engsbro,
Issue Highlights Clinical Gastroenterology and Hepatology
Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea  Shin Fukudo, Motoko Ida, Hiraku Akiho, Yoshihiro.
Erick Alayo, Bashar Attar, Benjamin Go 
Volume 139, Issue 6, Pages e2 (December 2010)
Adverse Outcomes: Why Bad Things Happen to Good People
Thomas G. Cotter, John S. Van Arnam, John A. Schaffner 
Kevin P. Quinn, James H. Tabibian, Seth Sweetser 
Metastatic Malignant Melanoma of the Gastrointestinal Tract
Self-Administered Cognitive Behavior Therapy for Moderate to Severe Irritable Bowel Syndrome: Clinical Efficacy, Tolerability, Feasibility  Jeffrey M.
Presentation transcript:

Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial  Robert J. Shulman, Emily B. Hollister, Kevin Cain, Danita I. Czyzewski, Mariella M. Self, Erica M. Weidler, Sridevi Devaraj, Ruth Ann Luna, James Versalovic, Margaret Heitkemper  Clinical Gastroenterology and Hepatology  Volume 15, Issue 5, Pages 712-719.e4 (May 2017) DOI: 10.1016/j.cgh.2016.03.045 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Abdominal pain symptoms. The reduction in (A) pain frequency but not (B) severity was significantly different between groups. The same Figure legends are used for Figures 2-4. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Figure 2 Stool characteristics. (A) Percent of stools that were classified as normal did not differ between groups. (B) There were a lower percentage of stools classified as constipation in the placebo group. (C) There was a trend for a lower percentage of stools to be classified as diarrhea in the fiber group. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Figure 3 Breath hydrogen and methane production. There were no differences between groups in (A) hydrogen or (B) methane area under the curve. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Figure 4 Gut permeability. (A) The percent sucrose recovery was similar between groups. (B) The lactulose/mannitol ratio was similar between groups. (C) The percent sucralose recovery was similar between groups. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 1 Study design. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 2 Consort diagram. The majority of children who dropped out did so before starting treatment. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions

Supplementary Figure 3 Stool microbiome composition. There was a trend at baseline toward (A) increased Bacteroidetes and decreased Firmicutes in the fiber group, and a similar trend at the (B) class level with Bacteroidia, whereas the (C) placebo group was marginally enriched in Clostridia. Clinical Gastroenterology and Hepatology 2017 15, 712-719.e4DOI: (10.1016/j.cgh.2016.03.045) Copyright © 2017 AGA Institute Terms and Conditions